FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Nearly a year after Montana began receiving millions of dollars to invest in efforts to combat the opioid crisis, much
Read MoreSome Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the
Read MorePatients with recurrent migraines often experience significant impairment as a result of their condition, which negatively affects their quality of
Read MoreDecember 12, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreKetogenic diets have been found to undermine exercise efforts and lead to muscle shrinkage and bone loss. An official International Society
Read MoreTo tackle America’s gun problem, a growing number of states are allowing Medicaid dollars to fund community-based violence programs intended
Read MoreDecember 12, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreNoam N. Levey Across the country, Americans are losing their homes, emptying their retirement accounts, and struggling to feed and
Read MoreSopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has scrapped
Read MoreLOS ANGELES — Los Angeles County public schools are rolling out an ambitious effort to offer free mental health services
Read More